CBS 2019
CBSMD教育中心
中 文

药物涂层球囊

Abstract

Recommended Article

Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review Therapeutic efficacy of paclitaxel-coated balloon for de novo coronary lesions with diameters larger than 2.8 mm Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons

Review Article2022 Apr 12;121742.

JOURNAL: Int J Pharm. Article Link

Mathematical modelling of endovascular drug delivery: balloons versus stents

J Escuer, AF Schmidt, S McGinty Keywords: DCB; DES; pharmacokinetics; computational modelling

Full Text PDF